WAM
AZN icon

World Asset Management’s AstraZeneca AZN Stock Holding History

World Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,454
Closed -$1.11M – 782
2020
Q1 		$1.11M Hold
12,454
– – 0.1% 201
2019
Q4 		$1.24M Sell
12,454
-3,383
-21% -$318K 0.06% 322
2019
Q3 		$1.41M Sell
15,837
-3,182
-17% -$276K 0.07% 281
2019
Q2 		$1.57M Sell
19,019
-124
-0.6% -$9.72K 0.08% 260
2019
Q1 		$1.55M Hold
19,143
– – 0.08% 252
2018
Q4 		$1.45M Sell
19,143
-13,044
-41% -$1.02M 0.09% 224
2018
Q3 		$2.55M Sell
32,187
-5,736
-15% -$434K 0.12% 177
2018
Q2 		$2.66M Sell
37,923
-12,405
-25% -$892K 0.13% 173
2018
Q1 		$3.52M Sell
50,328
-21,184
-30% -$1.47M 0.16% 138
2017
Q4 		$4.96M Sell
71,512
-2,799
-4% -$189K 0.17% 129
2017
Q3 		$5.04M Sell
74,311
-194
-0.3% -$12.3K 0.17% 128
2017
Q2 		$5.08M Sell
74,505
-4,321
-5% -$282K 0.18% 125
2017
Q1 		$4.91M Buy
78,826
+1,148
+1% +$66.8K 0.16% 143
2016
Q4 		$4.24M Sell
77,678
-6,911
-8% -$392K 0.16% 143
2016
Q3 		$5.56M Buy
84,589
+6,330
+8% +$414K 0.2% 106
2016
Q2 		$4.72M Buy
78,259
+6,017
+8% +$349K 0.18% 124
2016
Q1 		$4.07M Buy
72,242
+5,187
+8% +$312K 0.16% 141
2015
Q4 		$4.55M Buy
67,055
+1,544
+2% +$101K 0.17% 127
2015
Q3 		$4.17M Buy
65,511
+5,316
+9% +$350K 0.17% 132
2015
Q2 		$3.83M Sell
60,195
-3,919
-6% -$268K 0.15% 158
2015
Q1 		$4.39M Sell
64,114
-478
-0.7% -$33.2K 0.15% 148
2014
Q4 		$4.55M Sell
64,592
-478
-0.7% -$34.2K 0.16% 141
2014
Q3 		$4.65M Sell
65,070
-3,566
-5% -$261K 0.14% 156
2014
Q2 		$5.1M Sell
68,636
-2,091
-3% -$151K 0.16% 149
2014
Q1 		$4.59M Sell
70,727
-7,972
-10% -$515K 0.14% 157
2013
Q4 		$4.67M Sell
78,699
-25,526
-24% -$1.39M 0.13% 188
2013
Q3 		$5.41M Sell
104,225
-20,815
-17% -$1.05M 0.13% 179
2013
Q2 		$5.91M Buy
+125,040
New +$6.37M 0.14% 169

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

World Asset Management's AZN Position: Q2 2020 in Review

World Asset Management sold out of AstraZeneca (AZN) in Q2 2020, closing a stake of 12,454 shares — an estimated $1.11M sold.

World Asset Management first reported a position in AZN in Q2 2013 and held it in 28 quarters. The position peaked at $5.91M in Q2 2013. 669 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

  • World Asset Management reported no remaining AstraZeneca position as of Q2 2020 after selling out during the quarter.
  • World Asset Management sold 12,454 AstraZeneca shares in Q2 2020, an estimated $1.11M.
  • World Asset Management first reported a position in AstraZeneca in Q2 2013 and held it in 28 quarters.
  • World Asset Management's AstraZeneca position peaked at $5.91M in Q2 2013.
  • 669 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on World Asset Management's 13F filing for Q2 2020, filed 24 Jul 2020.